https://www.marketscreener.com/news/novartis-ianalumab-receives-fda-breakthrough-therapy-designation-for-sjogren-s-disease-ce7e58dfd980f02d
Novartis announced that the US Food and Drug Administration has granted Breakthrough Therapy designation to ianalumab for Sjogren's disease, the second most...
breakthrough therapynovartisianalumabreceivesfda